Guangzhou Wondfo Biotech Co Ltd
300482
Company Profile
Business description
Guangzhou Wondfo Biotech Co Ltd is engaged in the research, development, production and sales of POCT-related products such as rapid diagnostic reagents and rapid testing instruments. Its products are sold in various countries and regions, and are widely used in clinical testing, critical care, chronic disease management, primary healthcare, epidemic monitoring, disaster relief, on-site law enforcement, and family and personal health management.
Contact
No. 8, Lizhishan Road
Science City
Luogang District, Guangdong Province
Guangzhou510641
CHNT: +86 2032215701
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
2,443
Stocks News & Analysis
stocks
Wide moat ASX share beats earnings guidance
Wide moat share continues to grow despite a challenging residential construction market.
stocks
Cheap with attractive yield: Fair Value lifted for retail REIT after earnings
Management expects both earnings and distributions to increase next year.
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,443.70 | 17.90 | 0.19% |
| CAC 40 | 8,726.03 | 11.10 | 0.13% |
| DAX 40 | 26,323.88 | 4.43 | 0.02% |
| Dow JONES (US) | 53,975.98 | 60.95 | -0.11% |
| FTSE 100 | 10,862.50 | 38.59 | -0.35% |
| HKSE | 25,667.08 | 270.41 | -1.04% |
| NASDAQ | 26,605.36 | 85.26 | -0.32% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,860.66 | 27.58 | -0.20% |
| S&P 500 | 7,753.11 | 4.53 | -0.06% |
| S&P/ASX 200 | 9,250.60 | 13.80 | 0.15% |
| SSE Composite Index | 3,934.88 | 31.71 | -0.80% |